FCH
WST icon

Freestone Capital Holdings’s West Pharmaceutical WST Stock Holding History

Freestone Capital Holdings’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-880
Closed -$361K – 593
2022
Q1 		$361K Buy
880
+228
+35% +$89.3K 0.01% 429
2021
Q4 		$306K Buy
652
+103
+19% +$44.3K 0.01% 399
2021
Q3 		$233K Buy
+549
New +$231K 0.01% 383
2021
Q1 		– Sell
-200
Closed -$56.7K – 1143
2020
Q4 		$56.7K Buy
200
+62
+45% +$17.4K ﹤0.01% 536
2020
Q3 		$37.9K Buy
+138
New +$36.5K ﹤0.01% 529

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Freestone Capital Holdings's WST Position: Q2 2022 in Review

Freestone Capital Holdings sold out of West Pharmaceutical (WST) in Q2 2022, closing a stake of 880 shares — an estimated $361K sold.

Freestone Capital Holdings first reported a position in WST in Q3 2020 and held it in 5 quarters. The position peaked at $361K in Q1 2022. 655 funds tracked by Wall St. Rank hold WST as of Q2 2022.

  • Freestone Capital Holdings reported no remaining West Pharmaceutical position as of Q2 2022 after selling out during the quarter.
  • Freestone Capital Holdings sold 880 West Pharmaceutical shares in Q2 2022, an estimated $361K.
  • Freestone Capital Holdings first reported a position in West Pharmaceutical in Q3 2020 and held it in 5 quarters.
  • Freestone Capital Holdings's West Pharmaceutical position peaked at $361K in Q1 2022.
  • 655 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2022.

Based on Freestone Capital Holdings's 13F filing for Q2 2022, filed 9 Aug 2022.